8-K Announcements
6Material company update
May 21, 2026·SEC
Material company update
May 14, 2026·SEC
Material company update
Mar 18, 2026·SEC
Harte Hanks, Inc.(HHS)Earnings, Financials & Key Ratios
HHS•NASDAQ
Price updated Jun 19, 2026
SectorCommunication ServicesIndustryAdvertising & MarketingSub-IndustryPerformance and commerce marketing
AboutHarte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company provides strategic guidance to help clients to plan and execute omni-channel marketing programs; audience identification, profiling, segmentation and prioritization, predictive modeling, and data strategy services; data hygiene and cleansing services; print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice services; Website and app development, e-commerce enablement, database building and management, platform architecture creation, and marketing automation services; and outsourcing marketing operations solutions. It also offers customer experience management services comprising interact and resolve consumer concerns across hardware and software platforms, healthcare benefit plans, and recalls or a myriad of other customer service issues; CRM and digital transformation solutions to create meaningful customer interactions by connecting content between agent or AI-driven interfaces and web-based self-help tools and community forums; and intelligence-based B2B solutions that understand audiences and their behaviors, and then inspire and drive action to deliver results. In addition, the company provides product, print-on-demand, and mail fulfillment solutions, such as printing on demand, managing product recalls, and distributing literature and promotional products; custom solutions to engage audiences, target customers, support conferences, and appreciate employees; and third-party logistics and freight optimization services. It primarily serves B2B, consumer brand, financial services, retail, and healthcare vertical markets. Harte Hanks, Inc. was founded in 1923 and is headquartered in Chelmsford, Massachusetts.Show more
- Revenue$160M-13.9%
- EBITDA$7M+2.5%
- Net Income-$811K+97.3%
- EPS (Diluted)-0.11+97.3%
- Gross Margin68.73%-1.0%
- EBITDA Margin4.16%+19.0%
- Operating Margin1.36%+20.2%
- Net Margin-0.51%+96.9%
- ROE-3.84%+97.4%
HHS Key Insights
Harte Hanks, Inc. (HHS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Trading at only 0.9x book value
- ✓Efficient asset utilization: 1.7x turnover
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Thin 5Y average net margin of 1.6%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when HHS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HHS Price & Volume
Harte Hanks, Inc. (HHS) stock price & volume — 10-year historical chart
Loading chart...
HHS Growth Metrics
Harte Hanks, Inc. (HHS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-10.71%
5 Years-2.04%
3 Years-8.2%
TTM-14.38%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM96.57%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM96.67%
Return on Capital
10 Years-11.5%
5 Years8.56%
3 Years3.46%
Last Year3.38%
HHS Peer Comparison
Harte Hanks, Inc. (HHS) competitors in Performance and commerce marketing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 STGW | 1.7B | 6.71 | 61 | 2.39% | 0.64% | 2.45% | 2.00 | |
 KFRC | 829.64M | 45.39 | 23.16 | -5.43% | 2.6% | 27.22% | 0.56 | |
 MMS | 2.93B | 55.74 | 10.12 | 2.36% | 7.02% | 21.75% | 0.86 | |
 ICLR | 11.18B | 146.00 | 50.34 | -0.37% | 5.98% | 5.2% | 0.39 | |
 TTEC | 104.13M | 2.14 | -0.54 | -3.2% | -9.6% | -101.92% | 8.86 | |
 TASK | 442.95M | 4.91 | 4.46 | 18.95% | 8.7% | 21.23% | 0.50 | |
 EXLS | 4.06B | 25.93 | 16.84 | 13.56% | 11.66% | 27.16% | 0.44 | |
 CNXN | 1.78B | 70.57 | 21.58 | 2.52% | 3.02% | 9.67% | 0.00 |
Compare HHS vs Peers
Harte Hanks, Inc. (HHS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HHS Income Statement
Harte Hanks, Inc. (HHS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 383.91M | 284.63M | 217.58M | 176.9M | 194.6M | 206.28M | 191.49M | 185.24M | 159.57M | 155.27M |
Revenue Growth % | -5.07% | -25.86% | -23.56% | -18.7% | 10% | 6% | -7.17% | -3.26% | -13.86% | -14.38% |
Cost of Goods Sold | 109.09M | 100.25M | 75.9M | 49.29M | 50.26M | 65.7M | 59.57M | 56.64M | 49.9M | 111.99M |
COGS % of Revenue | 28.42% | 35.22% | 34.88% | 27.86% | 25.83% | 31.85% | 31.11% | 30.58% | 31.27% | - |
Gross Profit | 274.82M▲ 0% | 184.38M▼ 32.9% | 141.68M▼ 23.2% | 127.61M▼ 9.9% | 144.33M▲ 13.1% | 140.58M▼ 2.6% | 131.92M▼ 6.2% | 128.6M▼ 2.5% | 109.67M▼ 14.7% | 43.28M▲ 0% |
Gross Margin % | 71.58% | 64.78% | 65.12% | 72.14% | 74.17% | 68.15% | 68.89% | 69.42% | 68.73% | 27.87% |
Gross Profit Growth % | -4.34% | -32.91% | -23.16% | -9.93% | 13.1% | -2.6% | -6.16% | -2.52% | -14.72% | - |
Operating Expenses | 281.17M | 205.52M | 163.28M | 138.19M | 136.69M | 125.47M | 128.56M | 126.5M | 107.5M | 42.66M |
OpEx % of Revenue | 73.24% | 72.21% | 75.05% | 78.12% | 70.24% | 60.83% | 67.14% | 68.29% | 67.37% | - |
Selling, General & Admin | 270.66M | 198.07M | 146.15M | 125.2M | 127.78M | 122.74M | 118.64M | 116.55M | 103.03M | 62.65M |
SG&A % of Revenue | 70.5% | 69.59% | 67.17% | 70.77% | 65.66% | 59.5% | 61.96% | 62.92% | 64.57% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | -6.06M | -3.93M | 17.14M | 12.99M | 8.92M | 2.73M | 9.92M | 9.96M | 4.47M | 0 |
Operating Income | -40.87M▲ 0% | -26.03M▲ 36.3% | -21.61M▲ 17.0% | -10.58M▲ 51.1% | 7.64M▲ 172.2% | 15.11M▲ 97.8% | 3.36M▼ 77.8% | 2.09M▼ 37.7% | 2.17M▲ 3.6% | 613K▲ 0% |
Operating Margin % | -10.64% | -9.15% | -9.93% | -5.98% | 3.93% | 7.32% | 1.75% | 1.13% | 1.36% | 0.39% |
Operating Income Growth % | 26.74% | 36.29% | 17.01% | 51.05% | 172.23% | 97.76% | -77.77% | -37.69% | 3.58% | - |
EBITDA | -30.36M | -18.58M | -16.27M | -6.96M | 10.2M | 17.84M | 7.6M | 6.48M | 6.64M | 5.1M |
EBITDA Margin % | -7.91% | -6.53% | -7.48% | -3.94% | 5.24% | 8.65% | 3.97% | 3.5% | 4.16% | 3.29% |
EBITDA Growth % | 30.1% | 38.79% | 12.47% | 57.2% | 246.5% | 74.89% | -57.41% | -14.72% | 2.5% | -16.05% |
D&A (Non-Cash Add-back) | 10.51M | 7.45M | 5.34M | 3.62M | 2.56M | 2.73M | 4.24M | 4.38M | 4.47M | 4.49M |
EBIT | -46.93M | -21.15M | -9.81M | -17.14M | 17.16M | 19.75M | 9.05M | 7.66M | 2.17M | 762K |
Net Interest Income | -4.83M | -1.55M | -1.26M | -1.16M | -903K | -438K | 135K | -187K | 0 | -264K |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 135K | 0 | 0 | 0 |
Interest Expense | 4.83M | 1.55M | 1.26M | 1.16M | 903K | 438K | 0 | 187K | 0 | 264K |
Other Income/Expense | -10.89M | 25.47M | -2.9M | -7.73M | 8.62M | 4.21M | -5.28M | -40.03M | -3.18M | -2.01M |
Pretax Income | -51.75M▲ 0% | -562K▲ 98.9% | -24.51M▼ 4261.4% | -18.31M▲ 25.3% | 16.26M▲ 188.8% | 19.31M▲ 18.8% | -1.92M▼ 109.9% | -37.93M▼ 1876.8% | -1.01M▲ 97.3% | -1.4M▲ 0% |
Pretax Margin % | -13.48% | -0.2% | -11.27% | -10.35% | 8.36% | 9.36% | -1% | -20.48% | -0.63% | -0.9% |
Income Tax | -9.89M | -18.11M | 1.75M | -16.61M | 1.29M | -17.46M | -349K | -7.64M | -197K | -352K |
Effective Tax Rate % | 19.12% | 3222.78% | -7.15% | 90.75% | 7.92% | -90.42% | 18.19% | 20.13% | 19.54% | 25.16% |
Net Income | -41.86M▲ 0% | 17.55M▲ 141.9% | -26.26M▼ 249.7% | -1.69M▲ 93.6% | 14.97M▲ 983.8% | 36.78M▲ 145.6% | -1.57M▼ 104.3% | -30.3M▼ 1829.7% | -811K▲ 97.3% | -1.05M▲ 0% |
Net Margin % | -10.9% | 6.17% | -12.07% | -0.96% | 7.69% | 17.83% | -0.82% | -16.36% | -0.51% | -0.67% |
Net Income Growth % | 68.03% | 141.93% | -249.65% | 93.55% | 983.77% | 145.65% | -104.27% | -1829.75% | 97.32% | 96.57% |
Net Income (Continuing) | -41.86M | 17.55M | -26.26M | -1.69M | 14.97M | 36.78M | -1.57M | -30.3M | -811K | -1.05M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -6.76▲ 0% | 2.80▲ 141.4% | -4.18▼ 249.3% | -0.34▲ 91.9% | 1.76▲ 617.6% | 4.75▲ 169.9% | -0.21▼ 104.4% | -4.15▼ 1876.2% | -0.11▲ 97.3% | -0.14▲ 0% |
EPS Growth % | 68.26% | 141.42% | -249.29% | 91.87% | 617.65% | 169.89% | -104.42% | -1876.19% | 97.35% | 96.67% |
EPS (Basic) | -6.76 | 2.81 | -4.18 | -0.34 | 1.85 | 4.98 | -0.21 | -4.15 | -0.11 | - |
Diluted Shares Outstanding | 6.19M | 6.27M | 6.28M | 6.47M | 7.21M | 7.4M | 7.31M | 7.29M | 7.39M | 7.42M |
Basic Shares Outstanding | 6.19M | 6.24M | 6.28M | 6.47M | 6.8M | 7.1M | 7.31M | 7.29M | 7.39M | 7.42M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
HHS Balance Sheet
Harte Hanks, Inc. (HHS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 103.21M | 104.99M | 79.3M | 86.24M | 75.38M | 66.31M | 65.21M | 53.61M | 46.32M | 45.78M |
Cash & Short-Term Investments | 8.4M | 20.88M | 34.12M | 29.41M | 11.91M | 10.36M | 18.36M | 9.93M | 5.59M | 4.54M |
Cash Only | 8.4M | 20.88M | 34.12M | 29.41M | 11.91M | 10.36M | 18.36M | 9.93M | 5.59M | 4.54M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 81.4M | 56.6M | 39.78M | 42.15M | 57.26M | 52.16M | 42.25M | 39.86M | 34.89M | 34.17M |
Days Sales Outstanding | 77.39 | 72.58 | 66.73 | 86.96 | 107.41 | 92.3 | 80.53 | 78.55 | 79.81 | 86.5 |
Inventory | 587K | 448K | 354K | 46K | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | 1.96 | 1.63 | 1.7 | 0.34 | - | - | - | - | - | - |
Other Current Assets | 3.9M | 2.54M | 1.75M | 4.99M | 4.25M | 1.61M | 2.69M | 2.31M | 5.84M | 7.08M |
Total Non-Current Assets | 27.61M | 20.18M | 36.16M | 33.26M | 32.49M | 53.67M | 65.86M | 48.17M | 45.51M | 44.62M |
Property, Plant & Equipment | 21.79M | 13.59M | 27.14M | 30.63M | 29.89M | 29.69M | 34.27M | 31.42M | 28.24M | 27.3M |
Fixed Asset Turnover | 17.62x | 20.94x | 8.02x | 5.78x | 6.51x | 6.95x | 5.59x | 5.90x | 5.65x | 5.56x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 2.4M | 1.93M | 295K | 295K | 295K |
Intangible Assets | 2.59M | 0 | 300K | 0 | 0 | 3.54M | 2.82M | 563K | 370K | 322K |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 0 | 5K | 5K |
Other Non-Current Assets | 3.23M | 6.59M | 3.46M | -4.11M | 2.6M | 1.74M | 758K | 717K | 559K | 16.71M |
Total Assets | 130.81M▲ 0% | 125.17M▼ 4.3% | 115.47M▼ 7.8% | 119.5M▲ 3.5% | 107.86M▼ 9.7% | 119.98M▲ 11.2% | 131.07M▲ 9.2% | 101.78M▼ 22.3% | 91.83M▼ 9.8% | 90.41M▲ 0% |
Asset Turnover | 2.93x | 2.27x | 1.88x | 1.48x | 1.80x | 1.72x | 1.46x | 1.82x | 1.74x | 1.68x |
Asset Growth % | -38.71% | -4.31% | -7.76% | 3.49% | -9.74% | 11.24% | 9.24% | -22.35% | -9.78% | -47.58% |
Total Current Liabilities | 67.25M | 54.16M | 45.53M | 47.19M | 42.44M | 43.57M | 48.11M | 35.14M | 30.16M | 30.73M |
Accounts Payable | 36.13M | 31.05M | 16.92M | 16.29M | 16.13M | 22.46M | 23.18M | 21.83M | 13.1M | 11.09M |
Days Payables Outstanding | 120.89 | 113.05 | 81.35 | 120.66 | 117.15 | 124.8 | 142.01 | 140.68 | 95.8 | 49.62 |
Short-Term Debt | 0 | 0 | 7.62M | 4.93M | 0 | 0 | 4.82M | 0 | 3.54M | 3.96M |
Deferred Revenue (Current) | 16.79M | 12.76M | 4.4M | 11.16M | 10.44M | 5.81M | 3.19M | 3.21M | 813K | 5.2M |
Other Current Liabilities | 13.49M | 8.61M | 10.67M | 2.9M | 2.29M | 2.86M | 11.31M | 3.15M | 12.71M | 13.1M |
Current Ratio | 1.53x | 1.94x | 1.74x | 1.83x | 1.78x | 1.52x | 1.36x | 1.53x | 1.54x | 1.49x |
Quick Ratio | 1.53x | 1.93x | 1.73x | 1.83x | 1.78x | 1.52x | 1.36x | 1.53x | 1.54x | 1.49x |
Cash Conversion Cycle | -41.53 | -38.84 | -12.92 | -33.36 | - | - | - | - | - | 36.87 |
Total Non-Current Liabilities | 98.2M | 80.47M | 109.89M | 115.71M | 80.41M | 57.61M | 63.11M | 56.08M | 41.14M | 39.58M |
Long-Term Debt | 0 | 14.2M | 18.7M | 22.17M | 5M | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 13.08M | 21.3M | 19.21M | 16.57M | 23.69M | 20.86M | 18.86M | 74.16M |
Deferred Tax Liabilities | 773K | -578K | 5.51M | 0 | 0 | 0 | 8.32M | 11.13M | 0 | 0 |
Other Non-Current Liabilities | 97.43M | 66.27M | 71.72M | 72.24M | 56.2M | 41.03M | 30.8M | 24.1M | 22.27M | 21.53M |
Total Liabilities | 165.45M | 134.64M | 155.43M | 162.9M | 122.85M | 101.18M | 111.22M | 80.09M | 71.3M | 70.3M |
Total Debt | 0 | 14.2M | 39.39M | 55.06M | 30.77M | 22.32M | 28.51M | 24.6M | 22.4M | 22.02M |
Net Debt | -8.4M | -6.68M | 5.27M | 25.65M | 18.86M | 11.96M | 10.14M | 14.66M | 16.82M | 17.48M |
Debt / Equity | - | - | - | - | - | 1.19x | 1.44x | 1.13x | 1.09x | 1.10x |
Debt / EBITDA | - | - | - | - | 3.02x | 1.25x | 3.75x | 3.80x | 3.37x | 4.31x |
Net Debt / EBITDA | - | - | - | - | 1.85x | 0.67x | 1.34x | 2.26x | 2.53x | 3.42x |
Interest Coverage | -9.72x | -13.63x | -7.77x | -14.73x | 19.01x | 45.09x | - | 40.98x | - | 2.89x |
Total Equity | -34.63M▲ 0% | -9.46M▲ 72.7% | -39.96M▼ 322.4% | -43.4M▼ 8.6% | -14.99M▲ 65.5% | 18.81M▲ 225.5% | 19.86M▲ 5.6% | 21.69M▲ 9.2% | 20.53M▼ 5.4% | 20.1M▲ 0% |
Equity Growth % | -1404.03% | 72.68% | -322.37% | -8.61% | 65.46% | 225.45% | 5.58% | 9.23% | -5.36% | -9.15% |
Book Value per Share | -5.59 | -1.51 | -6.36 | -6.71 | -2.08 | 2.54 | 2.72 | 2.97 | 2.78 | 2.71 |
Total Shareholders' Equity | -34.63M | -9.46M | -39.96M | -43.4M | -14.99M | 18.81M | 19.86M | 21.69M | 20.53M | 20.1M |
Common Stock | 12.07M | 12.12M | 12.12M | 12.12M | 12.12M | 12.22M | 12.22M | 12.22M | 12.22M | 12.22M |
Retained Earnings | 794.58M | 812.7M | 797.82M | 796.12M | 811.09M | 846.49M | 844.92M | 814.62M | 813.81M | 813.18M |
Treasury Stock | -1.25B | -1.25B | -1.24B | -1.18B | -1.09B | -1.01B | -951.08M | -915.75M | -900.09M | -898.53M |
Accumulated OCI | -44.3M | -46.48M | -63.13M | -65.61M | -53.33M | -48.3M | -44.09M | -13.6M | -14.98M | -14.98M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HHS Cash Flow Statement
Harte Hanks, Inc. (HHS) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -30.8M | -9.18M | 12.1M | -7.84M | -1.76M | 28.79M | 10.48M | -2.99M | -1.74M | -704K |
Operating CF Margin % | -8.02% | -3.23% | 5.56% | -4.43% | -0.91% | 13.96% | 5.47% | -1.61% | -1.09% | - |
Operating CF Growth % | -311.1% | 70.19% | 231.76% | -164.81% | 77.51% | 1733.13% | -63.61% | -128.51% | 41.91% | -161.96% |
Net Income | -41.86M | 17.55M | -26.26M | -1.69M | 14.97M | 36.78M | -1.57M | -30.3M | -811K | -1.05M |
Depreciation & Amortization | 10.5M | 7.45M | 5.34M | 3.62M | 2.56M | 2.73M | 4.24M | 4.38M | 4.47M | 4.49M |
Stock-Based Compensation | 2.66M | -581K | 1.07M | 764K | 1.47M | 2.35M | 1.42M | 1.93M | 258K | 157K |
Deferred Taxes | -10.96M | -1.65M | 996K | -244K | -10.72M | -19.84M | -1.47M | -9.28M | -928K | -917K |
Other Non-Cash Items | 39.74M | -25.63M | 7.58M | -3.94M | 913K | -1.01M | 380K | 33.9M | -3.1M | -2M |
Working Capital Changes | -30.89M | -6.33M | 23.37M | -6.34M | -10.96M | 7.79M | 7.49M | -3.63M | -1.63M | -1.38M |
Change in Receivables | 7.42M | 7.47M | 16.82M | -931K | -9.18M | 3.84M | 5.65M | 2.38M | 4.97M | 6.06M |
Change in Inventory | 251K | 139K | 94K | 308K | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -10.4M | 9.25M | -13.75M | -997K | -395K | 6.2M | 844K | -795K | -3.21M | -4.82M |
Cash from Investing | -5.67M | -52K | -2.6M | -775K | -2.9M | -11.49M | -2.31M | -3.74M | -2.76M | -3M |
Capital Expenditures | -5.68M | -4.21M | -2.9M | -2.7M | -3.05M | -5.8M | -2.81M | -3.75M | -2.76M | -3M |
CapEx % of Revenue | 1.48% | 1.48% | 1.33% | 1.53% | 1.57% | 2.81% | 1.47% | 2.02% | 1.73% | 1.93% |
Acquisitions | 18K | 3.93M | 300K | 1.92M | 146K | -5.75M | 500K | 0 | 1K | -1K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 18K | 225K | 0 | 0 | 0 | 57K | 3K | 2K | 0 | 0 |
Cash from Financing | -1.46M | 22.73M | 3.09M | 7.31M | -13.41M | -15.82M | -3.22M | -419K | 514K | 632K |
Debt Issued (Net) | -712K | 13.65M | 3.69M | 7.99M | -12.33M | -5.19M | -160K | -124K | -159K | -160K |
Equity Issued (Net) | -111K | 0 | 9K | -22K | -291K | -10.49M | -3.01M | -295K | -65K | -46K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -115K | -6K | -22K | -291K | -469K | -3.01M | -295K | -65K | -46K |
Other Financing | -635K | 9.08M | -616K | -653K | -795K | -131K | -45K | 0 | 738K | 838K |
Net Change in Cash | -37.61M▲ 0% | 12.48M▲ 133.2% | 13.24M▲ 6.0% | -560K▼ 104.2% | -18.43M▼ 3190.9% | -3.77M▲ 79.5% | 7.5M▲ 299.0% | -8.93M▼ 219.1% | -4.35M▲ 51.3% | -4.44M▲ 0% |
Free Cash Flow | -36.48M▲ 0% | -13.39M▲ 63.3% | 9.2M▲ 168.7% | -10.54M▼ 214.5% | -4.81M▲ 54.4% | 22.99M▲ 578.1% | 7.67M▼ 66.7% | -6.73M▼ 187.8% | -4.49M▲ 33.3% | -3.7M▲ 0% |
FCF Margin % | -9.5% | -4.7% | 4.23% | -5.96% | -2.47% | 11.15% | 4% | -3.63% | -2.82% | -2.38% |
FCF Growth % | -561.88% | 63.31% | 168.74% | -214.53% | 54.37% | 578.1% | -66.66% | -187.84% | 33.28% | -234.21% |
FCF per Share | -5.89 | -2.14 | 1.46 | -1.63 | -0.67 | 3.11 | 1.05 | -0.92 | -0.61 | -0.50 |
FCF Conversion (FCF/Net Income) | 0.74x | -0.52x | -0.46x | 4.63x | -0.12x | 0.78x | -6.67x | 0.10x | 2.14x | 3.54x |
Interest Paid | 292K | 0 | 0 | 0 | 490K | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 32.91M | 0 | 0 | 0 | 1.32M | 0 | 0 | 1.45M | 0 | 0 |
HHS Key Ratios
Harte Hanks, Inc. (HHS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | - | - | - | 1927.46% | -8.12% | -145.85% | -3.84% | -5.06% |
Return on Invested Capital (ROIC) | - | - | - | - | 148.23% | 65.43% | 8.29% | 4.73% | 4.41% | 1.22% |
Gross Margin | 71.58% | 64.78% | 65.12% | 72.14% | 74.17% | 68.15% | 68.89% | 69.42% | 68.73% | 27.87% |
Net Margin | -10.9% | 6.17% | -12.07% | -0.96% | 7.69% | 17.83% | -0.82% | -16.36% | -0.51% | -0.67% |
Debt / Equity | - | - | - | - | - | 1.19x | 1.44x | 1.13x | 1.09x | 1.10x |
Interest Coverage | -9.72x | -13.63x | -7.77x | -14.73x | 19.01x | 45.09x | - | 40.98x | - | 2.89x |
FCF Conversion | 0.74x | -0.52x | -0.46x | 4.63x | -0.12x | 0.78x | -6.67x | 0.10x | 2.14x | 3.54x |
Revenue Growth | -5.07% | -25.86% | -23.56% | -18.7% | 10% | 6% | -7.17% | -3.26% | -13.86% | -14.38% |
Related:HHS Dividend History·HHS Revenue History·HHS Price History·HHS P/E History·HHS Financial Ratios·HHS Institutional Holders
HHS SEC Filings & Documents
Harte Hanks, Inc. (HHS) SEC filings — annual & quarterly reports (10-K, 10-Q)
HHS Frequently Asked Questions
Harte Hanks, Inc. (HHS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Harte Hanks, Inc. (HHS) reported $155.3M in revenue for fiscal year 2025. This represents a 77% decrease from $665.9M in 1996.
Harte Hanks, Inc. (HHS) saw revenue decline by 13.9% over the past year.
Harte Hanks, Inc. (HHS) reported a net loss of $1.0M for fiscal year 2025.
Dividend & Returns
Harte Hanks, Inc. (HHS) has a return on equity (ROE) of -3.8%. Negative ROE indicates the company is unprofitable.
Harte Hanks, Inc. (HHS) had negative free cash flow of $3.7M in fiscal year 2025, likely due to heavy capital investments.